businesspress24.com - Mettrum Announces First Quarter 2017 Financial Results Notification
 

Mettrum Announces First Quarter 2017 Financial Results Notification

ID: 1452068

(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 08/11/16 -- Mettrum Health Corp. ("Mettrum" or the "Company") (TSX VENTURE: MT), a vertically integrated health and wellness company focused on research, development, production and distribution of cannabis products, is pleased to announce that it will report its first quarter 2017 financial results for the period ended June 30, 2016, on August 22, 2016 after the close of market.

About Mettrum Health Corp.

Mettrum Health Corp. is a Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the Marihuana for Medical Purposes Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the "MMPR"), which came into effect on October 1, 2013. Mettrum received its first license from Health Canada under the MMPR on November 1, 2013 and began production of medical cannabis at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its other wholly-owned subsidiary, Agripharm Corp., at Mettrum Creemore facility in Clearview, Ontario. Mettrum received its third license from Health Canada under the MMPR on December 17, 2015 for Mettrum Ltd. at its new 60,000 square foot production and distribution facility in Bowmanville, Ontario. With the Company''s three licenses, Mettrum is a leading producer and vendor of medical cannabis under the MMPR system. In addition, through its wholly-owned subsidiary Mettrum Hempworks, Mettrum also is a licensed producer and distribution of industrial cannabis (hemp) products, including Mettrum''s functional food line, Mettrum Originals, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.







Contacts:
Mettrum Health Corp.
Ali Mahdavi
Director, Investor Relations
416.962.3300

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Fennec Announces Appointment of Marco Brughera to the Board of Directors
Medifirst Solutions Appoints Richard J. Berman to Its Advisory Board
Bereitgestellt von Benutzer: Marketwired
Datum: 11.08.2016 - 06:00 Uhr
Sprache: Deutsch
News-ID 1452068
Anzahl Zeichen: 2494

contact information:
Contact person:
Town:

TORONTO, ONTARIO


Phone:

Kategorie:

Alternative


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 110 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Mettrum Announces First Quarter 2017 Financial Results Notification
"
steht unter der journalistisch-redaktionellen Verantwortung von

Mettrum Health Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Mettrum Health Corp.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 53


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.